Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. - Wikidata - thesis-toulmin - TriplyDB

Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury.

Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury.

http://www.wikidata.org/entity/Q33808300

about

Recent advances in understanding and treating ARDS Analysis of time-resolved gene expression measurements across individuals Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury Prognostic and diagnostic value of plasma soluble suppression of tumorigenicity-2 concentrations in acute respiratory distress syndrome.Prediction of non-recovery from ventilator-demanding acute respiratory failure, ARDS and death using lung damage biomarkers: data from a 1200-patient critical care randomized trial.The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance.Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome.Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation Biomarkers of acute lung injury: worth their salt?Novel biomarker combination improves the diagnosis of serious bacterial infections in Malawian children.Proteomic profiles in acute respiratory distress syndrome differentiates survivors from non-survivors.Biomarkers in acute lung injury--marking forward progress.Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock Acute respiratory distress syndrome: A clinical review Prognostic factors in the acute respiratory distress syndrome Role of chemokines in the pathogenesis of acute lung injury.Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS.Acute respiratory distress syndrome: prevention and early recognition.Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study Improving risk classification of critical illness with biomarkers: a simulation study.Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.Biomarkers in acute respiratory distress syndrome: from pathobiology to improving patient care.Pathophysiology and biomarkers of acute respiratory distress syndrome.Emerging drugs for acute lung injury.MortalityPredictors.org: a manually-curated database of published biomarkers of human all-cause mortality.Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise.Incorporating Inflammation into Mortality Risk in Pediatric Acute Respiratory Distress Syndrome.Proteomic study of acute respiratory distress syndrome: current knowledge and implications for drug development.Current Concepts of ARDS: A Narrative Review.Biomarkers for patients with trauma associated acute respiratory distress syndrome.Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients.A new prediction score for critically ill patients-do we need an Apgar score for acute respiratory distress syndrome?Biology and pathology of fibroproliferation following the acute respiratory distress syndrome.A minimal net reclassification improvement to assess predictions of intensive care mortality.C-reactive protein 2 days after laparoscopic gastric bypass surgery reliably indicates leaks and moderately predicts morbidity.The definition of ARDS revisited: 20 years later.Neutrophil-to-lymphocyte ratio as a prognostic marker in acute respiratory distress syndrome patients: a retrospective study.Elevation of Serum PARK7 and IL-8 Levels Is Associated With Acute Lung Injury in Patients With Severe Sepsis/Septic Shock.

P2860

Q26751256-A4E5EE5B-2D7F-43DD-99CB-CAF2A0DE76F3 Q28536632-7035BE00-E774-47FB-AD26-CDCF75DB6E34 Q28727445-A7DD7908-7531-45CB-B7CE-9E19E9CB2693 Q30409730-B7CAC848-F7A3-4610-8674-219D697A5054 Q31143915-74D99001-0C34-474E-A58C-EA18D27CF514 Q33586556-2F9EE123-513B-42AE-BD0C-9E63C9285C52 Q33750995-9D22B619-5496-421F-93D4-64689DEE1E1A Q34073788-87551C4D-6FFF-4C3A-AE47-8E823B3E063B Q34094906-2CE0FD29-F173-45C5-B427-87E18ACF2ED6 Q34258071-243A47B4-9F8D-40C4-A5DB-1DD34D798329 Q34302302-DA9704C7-B150-4E55-89AB-FED8083A5907 Q35100674-B36E8534-6CDC-4D8D-BDB8-08A151D6DCDC Q35197349-8808FFD2-8E5D-4725-A6F9-C460988655B7 Q35412409-DE343882-2410-4452-9571-0466F4836140 Q35946855-DADFD451-151D-4B99-9B2C-6249196C329F Q35991282-B2FB7054-0998-4AAD-9090-2C495C808797 Q36539650-9A9ECB87-95DA-4C59-8F36-5C4C3393E84E Q36751000-07D72E0E-9BF3-4CEE-86DF-4C2C5D1ACC6C Q36803291-9264B393-B003-48F6-B970-3E87538F0AE3 Q36917451-4F5A8738-3DCA-4720-9EA6-D6238EECE8AF Q36997947-BA512B79-25A2-4F87-BE80-15B5F009749E Q37001346-AE0C541E-E579-45F5-9CF8-85CD99088427 Q37655890-BE16AC42-0356-4FAF-9B35-13C8360E6069 Q38215937-9D40D5D5-9768-4FE5-A27C-6F49F9E48AD4 Q38292758-5B20A60E-6C7F-4D32-B141-2B21F22BF7F2 Q38308143-B3E46480-F651-443F-B757-7AF97D536000 Q38599879-571FBBC4-18E2-4EFC-9705-9EC4DD26E40C Q38638963-71ED9CEB-39CC-4EC6-9470-48013CAD6B04 Q38751954-CF726CA8-20A2-48C7-9C24-23E5307DB570 Q38887825-5EB87A4B-87A9-4858-A2F1-5372ECA06E9E Q39063062-5DEE6ADF-9139-4AA4-BE88-5010905E6F29 Q41431807-2D77DCA9-2EDF-4993-90CB-DCEEA04E9E9A Q41650084-12033643-8482-4B98-8A3C-32C94B3FEC5F Q41877520-244A209C-B7BD-415B-A8C2-403F7E0653D6 Q42117783-762D30AD-265E-4E62-83DF-8C53C12CB0FD Q45343601-14EBA999-6166-44A7-B477-334BBCB5DCF5 Q46712420-FA0AE7A1-8043-4565-B831-04455D200338 Q51542201-C273E1D3-7A6E-499B-9F42-213F20EE015F Q52722988-BE6F1D5E-C9AF-4F43-8401-41C475066A03 Q53292003-CB86474C-5FCE-4DB8-A982-90CF7D739054

P2860

Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury.

http://www.wikidata.org/entity/Q33808300

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Use of risk reclassification w ...... ediction in acute lung injury.

@ast

Use of risk reclassification w ...... ediction in acute lung injury.

@en

type

label

Use of risk reclassification w ...... ediction in acute lung injury.

@ast

Use of risk reclassification w ...... ediction in acute lung injury.

@en

prefLabel

Use of risk reclassification w ...... ediction in acute lung injury.

@ast

Use of risk reclassification w ...... ediction in acute lung injury.

@en

P1433

Q33808300-8B712234-4CED-48B5-BDE0-312EB8326662

P1476

Q33808300-D1345666-EACC-451F-95FE-36D17D4DDC98

P2093

Q33808300-6368B150-EECF-4C02-9731-683F69BC2027

Q33808300-6DF5CADD-8CF3-4396-86A7-2DD9B4D53DBE

Q33808300-7D5AE6F6-119A-43FA-8396-EE8DC1D2A568

Q33808300-96FF4418-77BC-45BC-B648-388F3582107A

Q33808300-A049ACF3-CD5C-4134-A467-D9D64E602F42

P2860

Q33808300-012A0E09-AEF4-4F58-AB99-206DD41577A9

Q33808300-16113BFE-DB61-4719-893B-0B21BFB2974F

Q33808300-16769A80-7B0B-407F-AE8E-8251251E6658

Q33808300-1C489825-632C-4D30-A63F-436EE1663D06

Q33808300-3970DA65-E425-46FC-8BAA-9F4045942AEE

Q33808300-3E3810D9-94C6-4B01-A43D-241FEA087947

Q33808300-49C91305-8A83-477B-8FEA-0B1C9F7C7608

Q33808300-535A41B2-D290-4CDE-8F44-9B952BCEDBD8

Q33808300-5E604D9F-15FE-4096-BEE8-6E68720F8D2E

Q33808300-7D7EE782-EC38-4313-B645-1E495E3016DB

P304

Q33808300-45AE3318-C5A9-4FFA-AF8A-913620B4AE75

P31

Q33808300-CAEB269A-44CE-4AD5-ADC6-F3ED914B2B28

P356

Q33808300-7B9FF692-7E0B-4CBC-A62A-01EA214B68A6

P407

Q33808300-32AE5F90-5B3A-4861-90E4-0F36C67599D6

P433

Q33808300-2C0A5D6C-D1A6-460E-87C0-A9E879A19AE1

P478

Q33808300-F8662C74-0F50-40E2-AA62-E8419463459A

P50

Q33808300-9B23E500-5E65-4827-BD62-A1B028C65FEA

Q33808300-AD2F1D2D-C925-4E4C-B3B0-E0B91CEBFD23

Q33808300-D5F68CE1-2DCC-44EF-93B9-12B43938C58D

P577

Q33808300-3656FDF4-1AAB-4626-865C-F1E8FD4C447D

P698

Q33808300-861D3F4F-63D9-4C1B-B06D-C7D6A7214E68

P921

Q33808300-6D62F057-99CD-45CB-A180-6932E92C94B5

P932

Q33808300-4FF2CB8C-AEF2-4048-B053-7B254D2E75F0

P356

CCM.0B013E318207EC3C

P1433

Critical Care Medicine

P1476

Use of risk reclassification w ...... ediction in acute lung injury.

@en

P2093

B Taylor Thompson

http://www.w3.org/2001/XMLSchema#string

David V Glidden

http://www.w3.org/2001/XMLSchema#string

Mark D Eisner

http://www.w3.org/2001/XMLSchema#string

National Heart, Blood, and Lung Institute Acute Respiratory Distress Syndrome Network

http://www.w3.org/2001/XMLSchema#string

Polly E Parsons

http://www.w3.org/2001/XMLSchema#string

P2860

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Incidence and outcomes of acute lung injury

Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury

Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury

Beyond mortality: future clinical research in acute lung injury.

From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest.

Multiple biomarkers for the prediction of first major cardiovascular events and death.

The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults.

P304

711-717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CCM.0B013E318207EC3C

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

Lorraine B. Ware

Michael Matthay

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21283009

http://www.w3.org/2001/XMLSchema#string

P921

P932

3260884

http://www.w3.org/2001/XMLSchema#string